BIO Letter to Secretary Mayorkas on International Entrepreneur Rule
February 5, 2021
We encourage you to formally withdraw the proposed rule from the previous administration to remove IER, and to fully implement IER for the first time. The International Entrepreneur Rule would allow world-class foreign entrepreneurs to launch high-growth companies in the United States by utilizing the parole authority of the Department of Homeland Security (DHS). Unfortunately, the Trump Administration repeatedly sought to remove IER and block implementation before the program launched, thereby costing the United States jobs and innovation that are needed for our country to recover from the effects of the COVID-19 pandemic.
Download Full Comments Below
BIO Letter to Secretary Mayorkas on International Entrepreneur Rule
Dear Congressional Leaders:On behalf of the Council of State Bioscience Associations (CSBA)—a national coalition of independent, state and territory-based organizations representing the full breadth of America’s biotechnology ecosystem—we write to…
Re: Docket No. CDC-2025-0783; Advisory Committee on Immunization Practices (ACIP) MeetingDear Dr. Zadeh and Members of the ACIP:The Biotechnology Innovation Organization (BIO) appreciates the opportunity to provide comments to the Advisory Committee…
Chairman Cassidy, Ranking Member Sanders, and distinguished Members of the Committee:Thank you for the opportunity to appear before you today on behalf of the Biotechnology Innovation Organization (BIO), which represents more than 1,000…
We encourage you to formally withdraw the proposed rule from the previous administration to remove IER, and to fully implement IER for the first time. The International Entrepreneur Rule would allow world-class foreign entrepreneurs to launch high-growth companies in the United States by utilizing the parole authority of the Department of Homeland Security (DHS). Unfortunately, the Trump Administration repeatedly sought to remove IER and block implementation before the program launched, thereby costing the United States jobs and innovation that are needed for our country to recover from the effects of the COVID-19 pandemic.